Ulrich Krull completed his BSc, MSc and PhD (1983) degrees at the University of Toronto. He
is appointed as a Professor of Analytical Chemistry at the University of Toronto, and holds the
endowed AstraZeneca Chair in Biotechnology. He presently handles the portfolio of
Vice-Principal:Research at the University of Toronto Mississauga (UTM).
His professional interests focus in the area of biosensor research, and development of
molecular diagnostics technology for biomedical and environmental applications. His research
work is exploring the use of nanoscale materials and microfluidics chip technologies to build
devices for detection of DNA and RNA targets, and includes nanotechnology for real-time
intracellular determination of expression. Some of these device technologies are presently
being commercialized, and work by his research team has been fundamental in the launch of 4
start-up companies. Krull is recognized as one of the leading analytical chemists in
He has over 200 refereed publications, has co-authored more than 60 book chapters, has
co-edited 4 books and is an inventor listed on over a dozen patents. He is a Fellow of the
Chemical Institute of Canada. He has received both the McBryde Medal, and the Maxxam Award of
the Canadian Society for Chemistry (the top awards for analytical chemistry research in
Canada). He has been a recipient of the University of Toronto Faculty Excellence Award (top
award for research-teaching-service), as well as a Teaching Excellence Award.
Krull has served as the Associate Dean-Sciences, and also Vice-Dean:Graduate Affairs at UTM,
Vice-President of the Royal Canadian Institute, and is an editor of Analytica Chimica Acta, a
major international journal for analytical chemistry. He serves on a number of Advisory Boards
for industry, on Boards for organizations that support acceleration of commercialization
opportunities, and is Chair of the Healthy City Stewardship Centre.